文献速递前列腺癌

基于多参数MRI的前列腺癌侧别特异性包膜外侵犯预测列线图开发与内部验证

Development and internal validation of a side-specific, multiparametric magnetic resonance imaging-based nomogram for the prediction of extracapsular extension of prostate cancer.
PubMed 文献 · BJU Int · 2018-05-14

本研究回顾性分析561例机器人辅助根治性前列腺切除术患者,以829个侧别为单位构建预测侧别特异性包膜外侵犯(ECE)的列线图,纳入PSA、同侧最高活检Gleason分级、同侧最高穿刺针芯受累百分比及mpMRI显示的ECE。模型内部验证AUC为82.11%,校准良好,决策曲线分析显示净临床获益优于单独依赖mpMRI。

要点

  • 基于PSA、同侧Gleason分级、同侧针芯受累百分比和mpMRI ECE构建侧别特异性列线图。
  • 内部验证AUC为82.11%,校准优秀,净临床获益优于单独mpMRI预测。
  • 以20%概率阈值为神经保留决策参考时,14例ECE位点阳性切缘中9例高于阈值。

核心结论

  • 开发了易于使用的侧别特异性ECE预测列线图,有望辅助神经保留根治性前列腺切除术的规划并减少阳性切缘。

研究设计与样本

  • 以前列腺左右侧叶为单位分别分析,排除阴性活检观察293例后,最终纳入829个侧别病例。
  • 采用多变量逻辑回归分析预测侧别特异性ECE,基于logit函数系数构建列线图。
  • 内部验证采用留一交叉验证,通过图形评估校准,并采用决策曲线分析评估净临床获益。

主要发现

  • mpMRI报告ECE 115例(14%),最终病理报告ECE 142例(17.1%)。
  • 在最终病理确认ECE的病例中,mpMRI能正确预测ECE 57例(40.1%)。
  • 除最高针芯受累百分比外,其余变量(PSA、同侧最高活检Gleason分级、mpMRI ECE)均为ECE预测因素(所有P ≤ 0.006)。
  • 内部验证后模型AUC为82.11%,校准优秀,临床风险预测优于单独依赖mpMRI。
  • 回顾性应用列线图概率,以20%为神经保留阈值时,14例ECE位点阳性切缘中9例概率高于阈值。

关键数值与推荐

  • 列线图纳入四个变量:前列腺特异性抗原、同侧最高活检Gleason分级、同侧最高穿刺针芯受累百分比、mpMRI显示的ECE。
  • 内部验证AUC为82.11%。
  • 决策曲线分析显示模型净临床获益优于单独mpMRI预测ECE。
  • 以20%列线图概率作为神经保留决策阈值时,14例ECE位点阳性切缘中9例高于阈值。

临床怎么用

  • 列线图可用于术前规划神经保留根治性前列腺切除术,辅助判断侧别特异性ECE风险。
  • 以20%概率阈值参考决策神经保留,可能有助于降低ECE位点阳性切缘。
  • 模型预测性能优于单独依赖mpMRI,可整合mpMRI与临床病理变量进行综合评估。

局限性

  • 回顾性研究设计。
  • 仅进行内部验证,未进行外部验证。
  • 样本来自单一中心2014至2015年期间,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To develop a nomogram for predicting side-specific extracapsular extension (ECE) for planning nerve-sparing radical prostatectomy. MATERIALS AND METHODS: We retrospectively analysed data from 561 patients who underwent robot-assisted radical prostatectomy between February 2014 and October 2015. To develop a side-specific predictive model, we considered the prostatic lobes separately. Four variables were included: prostate-specific antigen; highest ipsilateral biopsy Gleason grade; highest ipsilateral percentage core involvement; and ECE on multiparametric magnetic resonance imaging (mpMRI). A multivariable logistic regression analysis was fitted to predict side-specific ECE. A nomogram was built based on the coefficients of the logit function. Internal validation was performed using 'leave-one-out' cross-validation. Calibration was graphically investigated. The decision curve analysis was used to evaluate the net clinical benefit. RESULTS: The study population consisted of 829 side-specific cases, after excluding negative biopsy observations (n = 293). ECE was reported on mpMRI and final pathology in 115 (14%) and 142 (17.1%) cases, respectively. Among these, mpMRI was able to predict ECE correctly in 57 (40.1%) cases. All variables in the model except highest percentage core involvement were predictors of ECE (all P ≤ 0.006). All variables were considered for inclusion in the nomogram. After internal validation, the area under the curve was 82.11%. The model demonstrated excellent calibration and improved clinical risk prediction, especially when compared with relying on mpMRI prediction of ECE alone. When retrospectively applying the nomogram-derived probability, using a 20% threshold for performing nerve-sparing, nine out of 14 positive surgical margins (PSMs) at the site of ECE resulted above the threshold. CONCLUSION: We developed an easy-to-use model for the prediction of side-specific ECE, and hope it serves as a tool for planning nerve-sparing radical prostatectomy and in the reduction of PSM in future series.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Martini A, Gupta A, Lewis SC, et al. Development and internal validation of a side-specific, multiparametric magnetic resonance imaging-based nomogram for the prediction of extracapsular extension of prostate cancer. BJU Int. 2018. PMID: 29676063. doi:10.1111/bju.14353

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。